Updated Jul 16, 2026
Lo Steven is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.

Steven Lo is a prominent executive in the biotechnology sector, currently serving as the President and Chief Executive Officer of Vaxart, Inc., a company focused on developing oral vaccines. He has a strong background in pharmaceutical development and business management, contributing significantly to the company's strategic direction and growth.
| Role | President, Chief Exec Officer, Director |
|---|---|
| Notability | 70/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-26 | VXRT | Vaxart, Inc. | F — Tax withholding / forfeiture | 126.0K | $0.69 | $87K |
| 2026-03-20 | VXRT | Vaxart, Inc. | F — Tax withholding / forfeiture | 22.4K | $0.63 | $14K |
| 2026-03-19 | VXRT | Vaxart, Inc. | A — Grant or award | 846.5K | $0.00 |
Steven Lo is a prominent executive in the biotechnology sector, currently serving as the President and Chief Executive Officer of Vaxart, Inc., a company focused on developing oral vaccines. He has a strong background in pharmaceutical development and business management, contributing significantly to the company's strategic direction and growth.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Lo Steven profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.